Why digital health technology is now a supply chain challenge, not just a technology one

The Clinical Trial industry has embraced Digital health Technology quickly and, in many respects, enthusiastically. Smartphones, tablets, wearables, and the software that runs on them have transformed how data is captured, how patients engage with studies, and how sponsors and CROs access real-time insights. But as adoption has accelerated, a practical challenge has moved to the top of the agenda: how do you actually get the right devices, configured correctly, to the right places - fast?

More than eCOA

It's worth starting with a common misconception. Clinical Trial devices are often discussed primarily in the context of eCOA, but the reality is much broader. A single device deployed in a study might simultaneously support an eCOA platform, an e-diary, a symptom tracker, a patient communication tool, and an investigator-facing application - all configured to protocol specifications and locked down to prevent unauthorized access. The versatility of modern clinical hardware is one of its greatest assets, but it also raises the bar for procurement. Getting a consumer smartphone is easy. Getting a study-ready device, validated for a specific protocol, configured for multiple applications, and ready to deploy across 30 countries, is a different challenge entirely.

The logistics reality

Global multi-site trials expose every weakness in a supply chain. Import regulations, customs requirements, and telecommunications rules vary considerably by region, and a device deployment that is straightforward in Western Europe can run into significant barriers in parts of Asia, Latin America, or the Middle East. Add fragmented vendor relationships - separate suppliers for hardware, connectivity, device management, and support - and you have a recipe for delays that ripple directly into site activation timelines.

Connectivity is another area that's often underestimated at the planning stage. Devices that rely on participants' own Wi-Fi or roaming SIMs introduce both security vulnerabilities and reliability risks. Purpose-built connectivity solutions, designed specifically for clinical use, ensure uninterrupted and secure data flow regardless of where in the world a participant happens to be.

Data security can't be an afterthought

For pharmaceutical companies, CROs, and software and data businesses operating in the clinical space, the data security requirements around patient-held devices are non-negotiable. Sensitive health data must be captured, transmitted, and stored in a way that is compliant across every jurisdiction a study touches. Mobile Device Management configurations that restrict devices to approved applications, enable remote management, and support audit trails are essential — not optional extras. Multi-language configuration adds another layer of protection, reducing user error and improving data quality at the source.

What this means for procurement

The good news is that with the right partner, much of this complexity can be taken off the table. A single-source supplier that handles device sourcing, configuration, connectivity, global logistics, and end-of-trial collection removes the fragmentation that creates risk. It also means one point of accountability when something needs to change mid-study - whether that's a replacement device shipped at short notice, a connectivity adjustment as a trial expands into a new market, or remote technical support for a participant in their native language.

At Woodley Trial Solutions, Digital Health Technology supply is something we've built dedicated capability around - combining our 35-year track record in global clinical trial equipment with deep expertise in the specific demands of connected device deployment. If you're planning a study that involves patient or site-held devices and want to talk through your requirements, please get in touch. We'd be delighted to help.